AGP Executive Report
Last update: 11 hours agoAssisted Dying in Focus: France’s National Assembly gave final approval to an assisted-dying bill for adults with incurable, life-threatening illnesses, but it still must go to the Constitutional Council before taking effect. Infectious Disease After-Effects: Charité experts warned that infections like flu and COVID can raise longer-term heart attack and stroke risk for weeks after the acute illness. Heat as a Health Crisis: Europe’s heat waves are driving major health impacts, with Germany seeing a sharp rise in heat-related deaths and drownings. Workforce & Care Access: Germany is stepping up recruitment of foreign nurses, including from Pakistan, to address staffing shortages—though recognition and licensing requirements remain a hurdle. Ebola Containment & Safety: A Bundibugyo Ebola case evacuated to Germany is being handled under high-containment standards, while travel restrictions aim to prevent importation. Obesity Drug Pipeline: Boehringer Ingelheim started a Phase II trial of BI 3034701, a triple GLP-1/GIP/NPY2 agonist candidate for obesity and overweight.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.